Search Results - Seth Lederman
- Showing 1 - 4 results of 4
-
1
Pooled Efficacy From Two Phase 3 Pivotal Trials (RELIEF AND RESILIENT) of TNX‐102 SL, Cyclobenzaprine HCl Sublingual Tablets, in Participants with Fibromyalgia Autoría: Errol Gould, Seth Lederman, Jean Engels, Julie Gubitz, Greg Sullivan
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Steady‐State Pharmacokinetic Properties of TNX‐102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized... Autoría: Gregory M. Sullivan, Bernd Meibohm, Errol Gould, Bruce L. Daugherty, Seth Lederman
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers Autoría: Bruce L Daugherty, Bernd Meibohm, Gregory M Sullivan, Errol M Gould, Seth Lederman
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Novel factors potentially initiating acute antibody‐mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimen Autoría: Kohei Kinoshita, Akihiro Maenaka, Ivy A. Rosales, Ahmad Karadagi, Toshihide Tomosugi, David Ayares, Seth Lederman, Robert B. Colvin, Tatsuo Kawai, Richard N. Pierson, Takaaki Kobayashi, David K. C. Cooper
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso